Delivery Order SPE2DB22D3016-SPE2DB25FBKU5
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Infanrix DTAP Syringe 0.5ML, a pediatric vaccine product, with a contract value of $1,391.22. The award was made on August 19, 2025, with an ultimate completion date of August 20, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a $1,913.65 delivery order to AmerisourceBergen Drug Corp for INFANRIX DTAP vaccine syringes (0.5mL) with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INFANRIX DTAP Syringe 0.5mL, a pediatric diphtheria, tetanus, and acellular pertussis vaccine. This firm fixed-price delivery order, valued at $3,091.60, represents a small-value pharmaceutical procurement supporting military and federal healthcare systems. The award is non-competitive and utilizes no set-aside designation, indicating fulfillment through an existing contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 2, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes. The contract, valued at $1,116.54, represents a firm fixed-price delivery order with an ultimate completion date of June 3, 2025, and carries no set-aside designation. This award was issued competitively and is performed at the vendor's location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,641.12 by the Defense Logistics Agency (DLA) on September 18, 2025, with an ultimate completion date of September 19, 2025. The contract, awarded under firm fixed pricing with no set-aside designation, calls for the delivery of Pediarix 0.5 mL syringes. This delivery order represents a single purchase transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,036.15 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, a pediatric vaccine product, with a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $10,820.60 to AmerisourceBergen Drug Corp for the supply of INFANRIX DTAP Syringe 0.5ML, a diphtheria, tetanus, and acellular pertussis vaccine. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by June 2, 2025. The vaccine will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,091.60 firm fixed-price contract is for the supply of INFANRIX DTAP SYRINGE 0.5ML, which is a vaccine product. The contract has an ultimate completion date of March 27, 2025 and was awarded on March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFANRIX DTAP SYRINGE 0.5ML, a vaccine product, with a ceiling value of $1,545.80 and a period of performance through May 1, 2025. The contract is not set-aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on May 30, 2025, for Boostrix TDAP vaccine in syringe form (0.5mL). This contract is a non-set-aside award with a ceiling value of $1,499.06 and a firm fixed price structure, with an ultimate completion date of June 2, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...